StockMarketWire.com - Kidney disease diagnostics group Renalytix welcomed an executive order signed by president Donald Trump to advance kidney health in the US.

The initiative was designed to improve the lives of Americans suffering from kidney disease, expand options for patients and reduce healthcare costs, the company said.

It would also set out policy to prevent kidney failure whenever possible through better diagnosis, treatment and incentives for preventative care.

RenalytixAI's is currently developing a product to improve the identification and clinical management of patients with type-2 diabetes with fast-progressing kidney disease.



Story provided by StockMarketWire.com